Evid Based Complement Alternat Med 2021 22;2021:5575453. Epub 2021 May 22.
Institute of Traditional Chinese Medicine of Respiratory Disease Prevention, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Objective: Qiyusanlong (QYSL) formula has been used in the clinic for more than 20 years and has been proved to have pronounced efficacy in the treatment of non-small-cell lung cancer (NSCLC). This work aims to evaluate the molecular mechanism of QYSL formula action on NSCLC, specifically in relation to autophagy induction.
Methods: In vitro, CCK-8 was used to detect the effect of QYSL serum on cell viability in A549 cells. Read More